ALIMERA SCIENCES, INC. SERIES B PREFERRED STOCK EXCHANGE AGREEMENTSeries B Preferred Stock Exchange Agreement • September 5th, 2018 • Alimera Sciences Inc • Pharmaceutical preparations • New York
This Series B Preferred Stock Exchange Agreement (the “Agreement”) is entered into as of this 4th day of September, 2018, by and among Alimera Sciences, Inc., a Delaware corporation (the “Corporation”), and the undersigned holders (each, a “Stockholder” and collectively, the “Stockholders”) of the Series B Convertible Preferred Stock, par value $0.01 per share, of the Corporation (the “Series B Preferred Stock”). Capitalized terms used and not otherwise defined herein shall have the meanings given to them in the Series C Preferred Stock Designation (as defined below).
